Immunization of HLA-A2+ melanoma patients with MAGE-3 or MelanA peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant human interleukin 12.
Year: 2001
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: T F Gajewski, F Fallarino, A Ashikari, M Sherman
Institution: University of Chicago
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1511686437
